EMTN Supplementary Prospectus 10 August 2022

Source: RNS
RNS Number : 6405V
Commonwealth Bank of Australia
11 August 2022


Publication of Supplementary Prospectus

The following supplementary prospectus (the Supplementary Prospectus) has been approved by the Financial Conduct Authority and is available for viewing:

Commonwealth Bank of Australia

U.S.$70,000,000,000 Euro Medium Term Note Programme

Supplementary Prospectus dated 10 August 2022 to the Programme Circular dated 30 June 2022 (as so supplemented, the "Programme Circular")

To view the full document, please paste the following URL into the address bar of your browser.

[RNS will insert the URL of your PDF prospectus]


For further information, please contact:

Commonwealth Bank of Australia
Level 1, 11 Harbour Street, Sydney, NSW, Australia, 2000

Telephone: +612 9118 1342


Please note that the information contained in the Supplementary Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Programme Circular) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Supplementary Prospectus is not addressed.  Prior to relying on the information contained in the Supplementary Prospectus you must ascertain from the Programme Circular whether or not you are part of the intended addressees of the information contained in the Supplementary Prospectus.

Your right to access this service is conditional upon complying with the above requirement.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.